Technology detects digital biomarkers to help monitor lung function and optimise therapeutic outcomes for patients electronRx to showcase pDx at HLTH 2025 (19–22 Oct, Las Vegas) Cambridge, UK, 18 ...
electronRx, a leading digital medicine and biomarker company driving healthcare through pulmonary innovation, today announced that it will launch pDx at HLTH 2025. The pDx app offers chronic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results